Gujarat varsity invites terror accused as chief guest for convocation

January 19, 2016

Ahmedabad, Jan 19: A university in Gujarat has kicked a row by inviting a top Rashtriya Swayamsevak Sangh (RSS) leader, who is also an accused in the Ajmer blast case, as the chief guest for the institution's annual convocation ceremony.

GujaratThe invitation to Indresh Kumar by the Hemchandracharya North Gujarat University has created a difference of opinion on and outside the campus, with many educationists in the state questioning the move.

As chief guest, Kumar will not only hand over gold medals to meritorious students, but also give a speech in the presence of governor OP Kohli on Monday.

The university said the decision to invite Kumar has been taken by vice-chancellor RL Godra himself. The invite calls the RSS leader "a social reformer and defence expert".

Kumar is one of the accused named in a CBI chargesheet on the blast at an Ajmer shrine in 2007, which killed three people and injured more than a dozen.

Interestingly, when a NavGujarat Samay reporter asked the registrar of the university Dr DM Patel about the invite, he said he had no idea who Indresh Kumar is. "The V-C fixed his name during a visit to Delhi," he said.

The RSS is the ideological mentor of the BJP.

Comments

THINKERS
 - 
Wednesday, 20 Jan 2016

Does Gujratis become sooooooooo weak to recognize the killers and the peace makers..?

Rikaz
 - 
Tuesday, 19 Jan 2016

No surprise, we have prime minister, who is the main reason for Gujrat carnage, no body gives damn on it....

Rahi
 - 
Tuesday, 19 Jan 2016

He is not accused, he is real terrorist and follower of India's first terrorist Nathuram Godse.

Goodman
 - 
Tuesday, 19 Jan 2016

Poor Gujaratis did not get any other person

May God help them to save the name of Gujarathis.

Ibrahim kunhi
 - 
Tuesday, 19 Jan 2016

unfair, so called secular india this s the hard example.

mohammed sadiq
 - 
Tuesday, 19 Jan 2016

if u wanna become famous like him, kill innocent people, its totally injustice to give him this respect.

Prem Sagar
 - 
Tuesday, 19 Jan 2016

wrongfully mentioned as terror accused, such a great person he is.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 20,2020

Bengaluru, Jul 20: Karnataka on Monday reported 3,648 COVID-19 cases taking the tally to 67,420, informed the state health department.

According to a bulletin issued by the department, the state recorded 72 more deaths due to COVID-19 with the toll at 1,403 while six patients who tested positive for the infection have died due to non-COVID causes, as of Monday.

There are 42,216 active cases in the state.
As many as 730 patients were discharged today, taking the total discharged patients to 23,795.
Bengaluru recorded the highest number of cases and deaths today at 1,452 and 31, respectively, informed the state health department.

India's COVID-19 case tally crossed the 11-lakh mark with the highest single-day spike of 40,425 new cases and 681 deaths reported in the last 24 hours, said the Union Health and Family Welfare Ministry on Monday.

The total cases in the country now stand at 1,118,043 while the death toll is 27,497.

The ministry said the total number of cases include 390,459 active cases and 700,087 cured/discharged/migrated.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 7,2020

Bengaluru, Mar 7: As a precautionary measure to control the spread of coronavirus in Karnataka, the state government has planned to suspend biometric attendance for the time-being at its offices, also in corporate and IT companies, Medical Education Minister Dr K Sudhakar said on Saturday.

He said the government has taken all precautionary measures to control the spread of the virus in the state.

"Our Additional Chief Secretary has already spoken to IT companies yesterday on behalf of the government regarding guidelines that need to be followed, it is part of it...we will do it in the government also in the days to come," Sudhakar told reporters here.

He was responding to a question about suspending biometric attendance at offices in the wake of the coronavirus outbreak.

Asked about suspending biometric attendanceat government offices, he said, "we have planned to do it yesterday."

Sudhakar said so far in Karnataka not even one case has been identified, to that extent we have been taking precautionary measures effectively.

He said from villages to state capital Bengaluru at all levels the health department officials have been activated as part of the precautionary measures.

Also, committees headed by Deputy Commissioners have been formed in all district, he added.

"We have given certain guidelines to people. We have also included private hospitals. We have taken all precautionary measures to stop the virus from entering the state," he added.

In response to a question regarding masks, the Minister clarified that those who have the symptoms of the disease only should use them.

He said, "N95 masks are required only for those who have tested positive, there is not even a single positive case in the state so far...surgical masks that will have three layers can be used by those who have symptoms like cough, cold, fever."

In the state as a precautionary measure 2,500 beds have been kept ready if the situation arises, despite not having a single case.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.